First developed in 2024 in partnership with global advocates and communities, the People’s Research Agenda sets out a people-centered framework for equitable and accelerated R&D and product introduction. The PRA tracks the science, shows where investments align—or fail to align—with community-defined priorities, and spotlights critical gaps in the pipeline of prevention options needed to meet the diverse realities of all populations.
- Featured speaker Jeanne Marrazzo, former Director of the National Institute of Allergy and Infectious Diseases and AVAC board member.
- We will cover what the People’s Research Agenda tracks, why it matters, and the advocacy priorities that will shape the future of prevention R&D.